Ting Li, Ruijuan Liu, Ye He, Bingge Zhang, Xuexiang Rui, Xifei Yang, Jian-Zhi Wang, Juan Zeng, Gang Li, Xiao Li, Gong-Ping Liu
{"title":"通过在早期和晚期激活自噬,过表达 TECPR1 可改善 P301S-tau 小鼠的认知功能。","authors":"Ting Li, Ruijuan Liu, Ye He, Bingge Zhang, Xuexiang Rui, Xifei Yang, Jian-Zhi Wang, Juan Zeng, Gang Li, Xiao Li, Gong-Ping Liu","doi":"10.1111/acel.14404","DOIUrl":null,"url":null,"abstract":"<p>Autophagy disorders in AD patients and animal models were well known, however, the effect of P301S-tau on autophagy is not clear. Here, we found that autophagy related protein Tectonin Beta-Propeller Repeat-Containing Protein 1 (TECPR1) decreased in the hippocampus of P301S-tau transgenic mice by proteomics, which was proved in vivo and in vitro, and P301S-tau induced autophagic deficits in early and late process. TECPR1 overexpression attenuated P301S-tau induced autophagy defects via promoting autophagosome generation and autophagosome and lysosomes fusion. We also found that TECPR1 overexpression ameliorated the behavior disorders of P301S-tau mice with promoting tau degradation, improving synaptic plasticity and neuron loss. Lastly, CQ or 3-MA treatment reversed TECPR1 induced improvement effects on autophagic and cognitive disorders, further proved that, TECPR1 activated the early and late process of autophagy to ameliorate the cognition of P301S-tau mice. Our data suggest that TECPR1 is a potential therapy target for AD.</p>","PeriodicalId":55543,"journal":{"name":"Aging Cell","volume":"24 3","pages":""},"PeriodicalIF":7.8000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acel.14404","citationCount":"0","resultStr":"{\"title\":\"Overexpression of TECPR1 improved cognitive function of P301S-tau mice via activation of autophagy in the early and late process\",\"authors\":\"Ting Li, Ruijuan Liu, Ye He, Bingge Zhang, Xuexiang Rui, Xifei Yang, Jian-Zhi Wang, Juan Zeng, Gang Li, Xiao Li, Gong-Ping Liu\",\"doi\":\"10.1111/acel.14404\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Autophagy disorders in AD patients and animal models were well known, however, the effect of P301S-tau on autophagy is not clear. Here, we found that autophagy related protein Tectonin Beta-Propeller Repeat-Containing Protein 1 (TECPR1) decreased in the hippocampus of P301S-tau transgenic mice by proteomics, which was proved in vivo and in vitro, and P301S-tau induced autophagic deficits in early and late process. TECPR1 overexpression attenuated P301S-tau induced autophagy defects via promoting autophagosome generation and autophagosome and lysosomes fusion. We also found that TECPR1 overexpression ameliorated the behavior disorders of P301S-tau mice with promoting tau degradation, improving synaptic plasticity and neuron loss. Lastly, CQ or 3-MA treatment reversed TECPR1 induced improvement effects on autophagic and cognitive disorders, further proved that, TECPR1 activated the early and late process of autophagy to ameliorate the cognition of P301S-tau mice. Our data suggest that TECPR1 is a potential therapy target for AD.</p>\",\"PeriodicalId\":55543,\"journal\":{\"name\":\"Aging Cell\",\"volume\":\"24 3\",\"pages\":\"\"},\"PeriodicalIF\":7.8000,\"publicationDate\":\"2024-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acel.14404\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Aging Cell\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/acel.14404\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging Cell","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/acel.14404","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
摘要
众所周知,AD 患者和动物模型存在自噬障碍,但 P301S-tau 对自噬的影响尚不清楚。在此,我们通过蛋白质组学研究发现,自噬相关蛋白Tectonin Beta-Propeller Repeat-Containing Protein 1(TECPR1)在P301S-tau转基因小鼠的海马中减少,这在体内和体外均得到了证实,并且P301S-tau诱导了早期和晚期过程中的自噬缺陷。通过促进自噬体的生成和自噬体与溶酶体的融合,TECPR1的过表达减轻了P301S-tau诱导的自噬缺陷。我们还发现,通过促进 tau 降解、改善突触可塑性和神经元丢失,过量表达 TECPR1 可改善 P301S-tau 小鼠的行为障碍。最后,CQ或3-MA处理逆转了TECPR1诱导的自噬和认知障碍改善效应,进一步证明了TECPR1激活了自噬的早期和晚期过程,从而改善了P301S-tau小鼠的认知。我们的数据表明,TECPR1是治疗AD的潜在靶点。
Overexpression of TECPR1 improved cognitive function of P301S-tau mice via activation of autophagy in the early and late process
Autophagy disorders in AD patients and animal models were well known, however, the effect of P301S-tau on autophagy is not clear. Here, we found that autophagy related protein Tectonin Beta-Propeller Repeat-Containing Protein 1 (TECPR1) decreased in the hippocampus of P301S-tau transgenic mice by proteomics, which was proved in vivo and in vitro, and P301S-tau induced autophagic deficits in early and late process. TECPR1 overexpression attenuated P301S-tau induced autophagy defects via promoting autophagosome generation and autophagosome and lysosomes fusion. We also found that TECPR1 overexpression ameliorated the behavior disorders of P301S-tau mice with promoting tau degradation, improving synaptic plasticity and neuron loss. Lastly, CQ or 3-MA treatment reversed TECPR1 induced improvement effects on autophagic and cognitive disorders, further proved that, TECPR1 activated the early and late process of autophagy to ameliorate the cognition of P301S-tau mice. Our data suggest that TECPR1 is a potential therapy target for AD.
期刊介绍:
Aging Cell, an Open Access journal, delves into fundamental aspects of aging biology. It comprehensively explores geroscience, emphasizing research on the mechanisms underlying the aging process and the connections between aging and age-related diseases.